Netherland, J., Botsko, M., Egan, J.E., Saxon, A., Cunningham, C., Finkelstein, R., Gourevitch, M.N., Renner, J., Sohler, N., Sullivan, L.E., Weiss, L., Fiellin, D.A., BHIVES Collaborative  (2009). Factors affecting willingness to provide buprenorphine treatment. Journal of Substance Abuse Treatment, 36(3), 244-251.

Barry, D.T., Irwin, K.S., Jones, E.S., Becker, W.C., Tetrault, J.M., Sullivan, L.E., Hansen, H., O'Connor, P.G., Schottenfeld, R.S., Fiellen D.A.  (2009). Integrating buprenorphine treatment into office-based practice: A qualitative study. Journal of General Internal Medicine, 24(2), 218-225.

Chaudhry, A.A., Gifford, A.L., Cofrancesco, J., Sosman, J, Berkenblit, G., Sullivan, L.E.  (2009). Update In HIV Medicine for the generalist. Journal of General Internal Medicine, 24(2), 276-82.

Sullivan, L.E., Fiellin, D.A.  (2008). Buprenorphine for opiod-dependent patients in office practice. Annals of Internal Medicine, 148(9), 662-670.

Sullivan, L.E., Moore, B.A., Chawarski, M.C., Pantalon, M.V., Barry, D.T., O’Connor, P.G., Schottenfeld, R.S., Fiellin, D.A.  (2008). Buprenorphine/naloxone treatment in primary care is associated with decreased HIV risk behaviors. Journal of Substance Abuse Treatment, 35(1), 87-92.

Tetrault, J.M., Desai, R.A., Becker, W.C., Fiellin, D.A., Concato, J., Sullivan, L.E.  (2008). Gender and non-medical use of prescription opoids: Results from a national U.S. survey. Addiction, 103(2), 258-268.

Fiellin, D.A., Moore, B.A., Sullivan, L.E., Becker, W.C., Pantalon, M.V., Chawarski, M.C., Barry, D.T., O'Connor, P.G., Schottenfeld, R.S.  (2008). Long-Term treatment with buprenorphine/naloxone in primary care: Results at 2-5 years. American Journal of Addictions, 17(2), 116-120.

Becker, W.C., Sullivan, L.E., Tetrault, J.M., Desai, R.A., Fiellin, D.A.  (2008). Non-Medical use, abuse and dependence on prescription opioids among U.W. adults: Psychiatric, medical and substance use correlates. Drug and Alcohol Dependence, 94(1-3), 38-47.

Gowing, L.R., Farrell, M., Borneman, R., Sullivan, L.E., Ali, R.L.  (2008, ). Substitution treatment of injecting opioid users for prevention of HIV infection. Cochrane Database of Systematic Reviews, pp. .

Sullivan L.E., Saitz R., Cheng D.M., Libman H., Nunes D., Samet J.H.  (2008). The impact of alcohol use on depressive symptoms in human immunodeficiency virus-infected patients. Addiction, 103(9), 1461-1467.

Sullivan, L.E., Levine, B.G., Chawarski, M.C., Schottenfeld, R.S., Fiellin, D.A.  (2007). Addiction and HIV in Kenya: A description of treatment services and integration. African Journal of Drug and Alcohol Studies, 6(1), 17-26.

Barry, D.T., Moore, B.A., Pantalon, M.V., Chawarski, M.C., Sullivan, L.E., O’Connor, P.G., Schottenfeld, R.S., and Fiellin, D.A.  (2007). Patient satisfaction with primary care office-based buprenorphine/naloxone treatment. Journal of General Internal Medicine, 22(2), 242-245.

Moore, B.A., Fiellin, D.A., Barry, D.T., Sullivan, L.E., Chawarski, M.C., O'Connor, P.G., and Schottenfeld, R.S.  (2007). Primary care office-based buprenorphine treatment: Comparison of heroin and prescription opioid dependent patients. Journal of General Internal Medicine, 22(4), 527-530.

Gordon, A.J., Sullivan, L.E., Alford, D.P., Arnsten, J.H., Gourevitch, M.N., Kertesz, S.G., Kunins, H.V., Merrill, J.O., Samet, J.H., and Fiellin, D.A.  (2007). Update in addiction medicine for the generalist. Journal of General Internal Medicine, 22(8), 1190-94.

Berkenblit, G., Sullivan, L.E., Sosman, J., Gifford, A., and Cofrancesco, J.  (2007). Update in HIV Care. Journal of General Internal Medicine, 22(2), 253-256.

Sullivan, L.E., Barry, D., Moore, B.A., Chawarski, M.C., Tetrault, J.M., Pantalon, M.V., O'connor, P.G., Schottenfeld, R.S., and Fiellin, D.A.  (2006). A Trial of Integrated Buprenorphine/Naloxone and HIV Clinical Care. Clinical Infectious Diseases, 43(Suppl 4), S184-S190.

Gowing, L.R., Farrell, M., Bornemann, R., Sullivan, L.E., and Ali, R.L.  (2006). BRIEF REPORT: Methadone Treatment of Injecting Opioid Users for Prevention of HIV Infection. Journal of General Internal Medicine, 21(2), 193-195.

Gunderson, E.W., Fiellin, D.A., Levin, F.R., Sullivan, L.E., and Kleber, H.D.  (2006). Evaluation of a combined online and in person training in the use of buprenorphine. Substance Abuse, 27(3), 39-45.

Sullivan, L.E., Bruce, R.D., Haltiwanger, D., Lucas, G.M., Eldred, L., Finkelstein, R., Fiellin, D.A.  (2006). Initial Strategies for Integrating Buprenorphine into HIV Care Settings in the United States. Clinical Infectious Diseases, 43(Suppl 4), S191-S196.

Altice, F.L., Sullivan, L.E., Smith-Rohrberg, D., Basu, S., Stancliff, S., and Eldred, L.  (2006). The Potential Role of Buprenorphine in the Treatment of Opioid Dependence in HIV-Infected Individuals and in HIV Infection Prevention. Clinical Infectious Diseases, 43(Suppl 4), S178-S183.

Sullivan, L.E., Fiellin, D.A., and O'Connor, P.G.  (2005). The prevalence and impact of alcohol problems in major depression: a systematic review. American Journal of Medicine, 118(4), 330-341.

Sullivan, L.E., and O'Connor, P.G.  (2004). Medical Disorders in Substance Abuse Patients. in Kranzler, H.R., and Tinsley, J.A., Dual Diagnosis and Treatment: Substance Abuse and Comorbid Disorders (pp.515-553). New York, NY: Marcel Dekker Inc..